No U.K. life sciences deal after EU council meeting

With the EU Council's June meeting now completed, the Association of the British Pharmaceutical Industry (ABPI) and the U.K.'s BioIndustry Association (BIA) said there is still no agreement on a deal for life sciences trade and regulation in the U.K. after its exit from the EU.

In a statement Friday, ABPI CEO Mike Thompson and BIA CEO Steve Bates said that with the U.K.'s exit from the EU fewer than nine months away, "as it stands we still do not have a deal on the future relationship or any certainty on the conditions our companies are expected to operate under come 29 March 2019."...